Erwin Schollmayer

1.3k total citations
27 papers, 950 citations indexed

About

Erwin Schollmayer is a scholar working on Neurology, Epidemiology and Cognitive Neuroscience. According to data from OpenAlex, Erwin Schollmayer has authored 27 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 24 papers in Epidemiology and 18 papers in Cognitive Neuroscience. Recurrent topics in Erwin Schollmayer's work include Parkinson's Disease Mechanisms and Treatments (24 papers), Restless Legs Syndrome Research (24 papers) and Sleep and Wakefulness Research (18 papers). Erwin Schollmayer is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (24 papers), Restless Legs Syndrome Research (24 papers) and Sleep and Wakefulness Research (18 papers). Erwin Schollmayer collaborates with scholars based in Germany, United States and Austria. Erwin Schollmayer's co-authors include Ralf Kohnen, Wolfgang H. Oertel, Karin Stiasny‐Kolster, Heike Beneš, Claudia Trenkwalder, Diego García‐Borreguero, Birgit Högl, Luigi Ferini‐Strambi, Andreas Fichtner and Werner Poewe and has published in prestigious journals such as Neurology, The Lancet Neurology and American Journal of Kidney Diseases.

In The Last Decade

Erwin Schollmayer

27 papers receiving 920 citations

Peers

Erwin Schollmayer

NEURO

EPIDE

PMH

NEPHR

Ayaka Numao Japan

Y. Naidu United Kingdom

Frank Grieger Germany

B. Hock Germany

Denise Sharon United States

Mitsuru Shiba Japan

Alice Barra Belgium

Nicolas Lejeune Belgium

Hassen Khan United States

Farah Atassi United States

Ayaka Numao Japan

Erwin Schollmayer

257 ×0.3

NEURO

156 ×0.2

EPIDE

89 ×0.1

42 ×0.5

PMH

11 ×0.2

NEPHR

Citations per year, relative to Erwin Schollmayer Erwin Schollmayer (= 1×) peers Ayaka Numao

Countries citing papers authored by Erwin Schollmayer

Since Specialization

Citations

This map shows the geographic impact of Erwin Schollmayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin Schollmayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin Schollmayer more than expected).

Fields of papers citing papers by Erwin Schollmayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin Schollmayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin Schollmayer. The network helps show where Erwin Schollmayer may publish in the future.

Co-authorship network of co-authors of Erwin Schollmayer

This figure shows the co-authorship network connecting the top 25 collaborators of Erwin Schollmayer. A scholar is included among the top collaborators of Erwin Schollmayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwin Schollmayer. Erwin Schollmayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dauvilliers, Yves, Heike Beneš, Markku Partinen, et al.. (2016). Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial. American Journal of Kidney Diseases. 68(3). 434–443. 33 indexed citations

Picchietti, Daniel L., Arthur S. Walters, Kimberly Moran, et al.. (2016). Pharmacokinetics of rotigotine transdermal system in adolescents with idiopathic restless legs syndrome (Willis–Ekbom disease). Sleep Medicine. 32. 48–55. 14 indexed citations

Trenkwalder, Claudia, Monica Canelo, Michael Lang, et al.. (2015). Management of augmentation of restless legs syndrome with rotigotine: a 1-year observational study. Sleep Medicine. 30. 257–265. 18 indexed citations

García‐Borreguero, Diego, Richard P. Allen, Elisabeth Dohin, et al.. (2015). Effects of rotigotine on daytime symptoms in patients with primary restless legs syndrome: a randomized, placebo-controlled study. Current Medical Research and Opinion. 32(1). 77–85. 13 indexed citations

Winkelman, John W., Yves Dauvilliers, Markku Partinen, et al.. (2015). Rotigotine in Patients with Restless Legs Syndrome and End-stage Renal Disease Requiring Hemodialysis (P7.298). Neurology. 84(14_supplement). 2 indexed citations

Oertel, Wolfgang H., Axel Bauer, Werner Cassel, et al.. (2014). Effect Of Rotigotine Transdermal System On Nocturnal Blood Pressure Changes Associated With Periodic Limb Movements During Sleep In Patients With Restless Legs Syndrome (P5.268). Neurology. 82(10_supplement). 1 indexed citations

Stiasny‐Kolster, Karin, Daniela Berg, Werner Hofmann, et al.. (2013). Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany. Sleep Medicine. 14(6). 475–481. 11 indexed citations

Allen, Richard P., Wolfgang H. Oertel, Arthur S. Walters, et al.. (2013). Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire. Sleep Medicine. 14(12). 1375–1380. 22 indexed citations

Beneš, Heike, Diego García‐Borreguero, Luigi Ferini‐Strambi, et al.. (2012). Augmentation in the treatment of restless legs syndrome with transdermal rotigotine. Sleep Medicine. 13(6). 589–597. 34 indexed citations

10.

Dohin, Elisabeth, Birgit Högl, Luigi Ferini‐Strambi, et al.. (2012). Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: apost-hocanalysis of patients taking 1 – 3 mg/24 h for up to 5 years. Expert Opinion on Pharmacotherapy. 14(1). 15–25. 10 indexed citations

11.

Oertel, Wolfgang H., Claudia Trenkwalder, Heike Beneš, et al.. (2011). Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study. The Lancet Neurology. 10(8). 710–720. 98 indexed citations

12.

Högl, Birgit, Wolfgang H. Oertel, Karin Stiasny‐Kolster, et al.. (2010). Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch. BMC Neurology. 10(1). 86–86. 31 indexed citations

13.

Oertel, Wolfgang H., Heike Beneš, Diego García‐Borreguero, et al.. (2010). Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: A randomized, placebo-controlled polysomnographic study. Sleep Medicine. 11(9). 848–856. 77 indexed citations

14.

Hening, Wayne A., Richard P. Allen, William G. Ondo, et al.. (2010). Rotigotine improves restless legs syndrome: A 6‐month randomized, double‐blind, placebo‐controlled trial in the United States. Movement Disorders. 25(11). 1675–1683. 87 indexed citations

15.

Oertel, Wolfgang H., Heike Beneš, Diego García‐Borreguero, et al.. (2008). One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome. Sleep Medicine. 9(8). 865–873. 43 indexed citations

16.

Trenkwalder, Claudia, Heike Beneš, Werner Poewe, et al.. (2008). Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. The Lancet Neurology. 7(7). 595–604. 154 indexed citations

17.

Oertel, Wolfgang H., Heike Beneš, Diego García‐Borreguero, et al.. (2007). Efficacy of rotigotine transdermal system in severe restless legs syndrome: A randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Medicine. 9(3). 228–239. 82 indexed citations

18.

Stiasny‐Kolster, Karin, et al.. (2004). Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: A double‐blind, placebo‐controlled pilot study. Movement Disorders. 19(12). 1432–1438. 108 indexed citations

19.

Sketch, Michael H., et al.. (2001). Prevention of Contrast Media-Induced Renal Dysfunction With Prostaglandin E 1 : A Randomized, Double-Blind, Placebo-Controlled Study. American Journal of Therapeutics. 8(3). 155–162. 51 indexed citations

20.

Lenz, K., et al.. (1997). EFFECT OF PROSTAGLANDIN E1 ON EXTRAVASCULAR LUNG WATER IN PATIENTS WITH SEVERE HEART FAILURE. American Journal of Therapeutics. 4(11). 389–394. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact